Planned enrollment decreased by 42 participants
Before: 258 participants (planned). After: 216 participants (planned).
Primary completion date changed
Before: Oct 2026. After: Aug 2027.
Study sponsor: Supernus Pharmaceuticals, Inc. · SUPN
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: 258 participants (planned). After: 216 participants (planned).
Before: Oct 2026. After: Aug 2027.